Approval · Notice of Compliance 14513 · 2013
PROPADERM: Notice of Compliance 14513
Issued July 3, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14513
- Date
- July 3, 2013
- Company
- Valeo Pharma Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative transfer of Drug Identification Numbers
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPADERM | 02089602 | Marketed |
Medicinal ingredients
- BECLOMETHASONE DIPROPIONATE 0.025 PER